Navigation Links
First study to show that bisphenol A exposure increases risk of future onset of heart disease

Bisphenol A (BPA) is a controversial chemical widely used in the plastics industry. A new study followed people over a 10-year time period and shows that healthy people with higher urine concentrations of BPA were more likely to later develop heart disease.

The study was carried out by researchers at the Peninsula College of Medicine and Dentistry, the University of Exeter and the European Centre for the Environment and Human Health, in association with the University of Cambridge. The analysis was funded by the British Heart Foundation. The paper is published online in Circulation a Journal of the American Heart Association.

The research team had previously identified the link between BPA and the increased risk of cardiovascular disease by using two sets of US data, which are effectively snapshots in time. The previous data showed a correlation between exposure to BPA and cardiovascular disease but it could not help researchers to predict how exposure to the chemical might affect future health.

The most recent study uses data from the European Prospective Investigation of Cancer (EPIC) in Norfolk, UK, a long term population study led by the University of Cambridge, supported by the Medical Research Council UK and Cancer Research UK. It is the first time that data has been used to establish a link between exposure to BPA and future onset of cardiovascular disease.

The study compared urine BPA measures from 758 initially healthy EPIC study respondents who later developed cardiovascular disease, and 861 respondents who remained heart disease free. The findings of the study show that those who developed heart disease tended to have higher urinary BPA concentrations at the start of the 10-year period. The extent of the effect is very difficult to estimate given that just one urine specimen from each participant was available for testing at the beginning of the 10-year follow-up.

Professor David Melzer of the Peninsula Medical School, who led the team, said: "This study strengthens the statistical link between BPA and heart disease, but we can't be certain that BPA itself is responsible. It is now important that government agencies organise drug style safety trials of BPA in humans, as much basic information about how BPA behaves in the human body is still unknown."

Professor Tamara Galloway of the University of Exeter, senior author on the paper, said: "If BPA itself is directly responsible for this increase in risk, the size of effect is difficult to estimate. However, it adds to the evidence that BPA may be an additional contributor to heart disease risk alongside the major risk factors, such as smoking, high blood pressure and high cholesterol levels."

BPA is one of the world's highest production volume chemicals. The global population is exposed to BPA primarily through packaged food and drink, but also through drinking water, dental sealants, exposure to the skin and the inhalation of household dust.


Contact: Andrew Gould
The Peninsula College of Medicine and Dentistry

Related biology news :

1. First vaccine against fatal visceral leishmaniasis enters clinical trial
2. New miniature grasshopper-like insect is first member of its family from Belize
3. St. Michaels and King Saud University receive first joint patent
4. First industrial-scale foam forming research environment for forest sector
5. St. Josephs receives Canadas first whole-body PET/MRI scanner
6. EASL publishes first European Clinical Practice Guidelines for Wilsons disease
7. First plants caused ice ages
8. UMass Amherst ecologists among the first to record and study deep-sea fish noises
9. Aria Diagnostics announces publication of first peer-reviewed data for new noninvasive prenatal test
10. OHSU research produces the worlds first primate chimeric offspring
11. UofL physicians, Jewish Hospital first in Kentucky to offer new aortic valve replacement
Post Your Comments:
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
(Date:6/23/2016)... 2016 Andrew D ... Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: